(19)
(11) EP 4 072 569 A1

(12)

(43) Date of publication:
19.10.2022 Bulletin 2022/42

(21) Application number: 21721385.9

(22) Date of filing: 25.03.2021
(51) International Patent Classification (IPC): 
A61K 35/14(2015.01)
B01D 61/00(2006.01)
 A61K 38/17(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/14; A61K 38/17; B01D 61/027; B01D 2311/10; B01D 61/58; B01D 61/145; B01D 71/56
(86) International application number:
PCT/CZ2021/000014
(87) International publication number:
WO 2021/249581 (16.12.2021 Gazette 2021/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 12.06.2020 CZ 20200342

(71) Applicant: Aumed, a.s.
14300 Praha 4 (CZ)

(72) Inventor:
  • VRONKA, Juraj
    16300 Praha 17 (CZ)

(74) Representative: Danek, Vilém 
Danek & Partners Vinohradská 17
120 00 Praha 2
120 00 Praha 2 (CZ)

   


(54) METHOD OF PREPARATION OF THE TRANSFER FACTOR MEDICINE, TRANSFER FACTOR MEDICINE, METHOD OF TESTING ITS BIOLOGICAL ACTIVITY, PHARMACEUTICAL FORM AND ITS USE